Parkinson's Disease Trial, Not Yet Recruiting NCT07418658 Sponsor: Universitaire Ziekenhuizen KU Leuven Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Not Yet Recruiting

NCT07418658
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

As a patient with Parkinson's Disease:

  • People who have been diagnosed with Parkinson's Disease by a neurologist, using recognised international diagnostic guidelines
  • People aged between 18 and 75 years old
  • People who are able to understand the study and its questionnaires, and follow the study requirements
  • People who have signed a consent form agreeing to take part

As a healthy control participant (no Parkinson's Disease):

  • People aged between 40 and 75 years old
  • People who are able to understand the study and its questionnaires, and follow the study requirements
  • People who have signed a consent form agreeing to take part

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

Applying to both patients and controls:

  • People who have been diagnosed with certain digestive or gastrointestinal conditions that could affect study results, such as inflammatory bowel disease, coeliac disease, gastrointestinal cancer, diverticulitis in the last 6 months, or a gastrointestinal infection in the last 3 months (confirm with trial site for full list)
  • People who have had major abdominal surgery, such as removal of the gallbladder or colon, or hiatal hernia repair — though some simpler surgeries such as appendix removal or inguinal hernia repair may not apply (confirm with trial site)
  • People who have ever taken medication used to treat the movement symptoms of Parkinson's Disease, such as levodopa, dopamine agonists, or related medicines
  • People who have taken antibiotics in the last 3 months
  • People who have taken proton pump inhibitors (a type of stomach acid medication) in the last month
  • People who have taken anti-inflammatory pain medicines (such as ibuprofen) in the last month
  • People who are on blood-thinning medications, including warfarin, direct oral anticoagulants, or blood clot prevention injections, or who are on a specific combination of two antiplatelet medicines (confirm with trial site)
  • People who are pregnant or breastfeeding
  • People who have had cancer or cancer treatment within the last 6 months
  • People who have had a food poisoning episode in the last 3 months
  • People who regularly drink more than 2 standard alcoholic drinks per day

Applying to patients only (additional criteria):

  • People who have a major neurological condition other than Parkinson's Disease

Applying to controls only (additional criteria):

  • People who have a diagnosis of Parkinson's Disease or any other major neurological condition
  • People who show physical signs associated with Parkinson's Disease or similar movement disorders
  • People who have a close blood relative (parent, sibling, or child) with Parkinson's Disease
  • People who meet the clinical diagnostic criteria for functional digestive conditions such as functional dyspepsia, functional constipation, or irritable bowel syndrome

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 February 2026
Est. completion
1 February 2029

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Paracellular flux; Transepithelial electrical resistance (TEER); Fecal microbiota composition; Duodenal microbiota composition

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov